PARP inhibitors for ovarian cancer

Ovarian Cancer: Moving to a Personalized Treatment ApproachПодробнее

Management of Relapsed/Refractory Ovarian CancerПодробнее

To modulate or to skip: De-escalating PARP inhibitor maintenance therapy in ovarian cancer...Подробнее

How to Approach to Ovarian Cancer from Community Oncology PerspectiveПодробнее

Optimizing Ovarian Cancer Care: Genetic Testing and Treatment ApproachesПодробнее

PFS increase but no OS increase for niraparib in advanced ovarian cancerПодробнее

Molecular Mechanism of PARP Inhibitor Resistance | OncoscienceПодробнее

Current Immunotherapy Options for Advanced Endometrial Cancer- 2024 Ovarian Cancer ProgramПодробнее

Parp Inhibitors, ओवरियन कैंसर के इलाज मे इतनी कारगर क्यों हैं? | Dr Sarika GuptaПодробнее

How Do Biomarkers Impact Ovarian Cancer Treatment and Care?Подробнее

Ovarian Cancer & PARP Inhibitors with Dr. B.S. Ankit Nehra | Oncology Perspective 2024Подробнее

My Journey with Ovarian Cancer, #10, PARP InhibitorsПодробнее

The ABCs of ADCs: Ovarian Cancer and Antibody Drug ConjugatesПодробнее

The Pulse on Progress - Insights into Ovarian CancerПодробнее

PARP Inhibitors in Ovarian Cancer Treatment: Understanding Side EffectsПодробнее

PARP Inhibitors in Prostate Cancer Treatment - Program: Patient Education Ambassadors 2023-24Подробнее

Advancing Therapeutic Paradigms for Ovarian Cancer in The Era of PARP Inhibitors: A Guide for The...Подробнее

Chemotherapy: PARP-inhibitors, Bevacizumab, and Ovarian CytotoxicsПодробнее

Clinical Advances in Ovarian Cancer: Exploring the Expanding Role of PARP Inhibitors in the Treat...Подробнее

What Clinical Trials Are Recruiting for Recurrent Ovarian Cancer?Подробнее